Henry Schein Inc. Stock
Henry Schein Inc. Stock
The price for the Henry Schein Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.680%).
Currently there is a rather positive sentiment for Henry Schein Inc. with 12 Buy predictions and 3 Sell predictions.
On the other hand, the target price of 68 € is below the current price of 74.5 € for Henry Schein Inc., so the potential is actually -8.72%.
Our community identified positive and negative aspects for Henry Schein Inc. stock for the coming years. 0 users see the criterium "Company culture" as a plus for the Henry Schein Inc. stock. On the other hand our users think that "Company culture" could be a problem in the future.
Pros and Cons of Henry Schein Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Henry Schein Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Henry Schein Inc. | -0.680% | -0.671% | 0.000% | 21.671% | 13.951% | 2.125% | 9.662% |
| Dexcom Inc. | 11.730% | 4.516% | 9.831% | -16.902% | 13.050% | -46.036% | -40.386% |
| Baxter International | -1.250% | 21.773% | 24.417% | -5.554% | 42.463% | -45.580% | -64.413% |
| Idexx Laboratories Inc. | 0.470% | 2.236% | 5.232% | -3.253% | -17.089% | -3.369% | -15.292% |
Comments
Henry Schein (HSIC) had its price target raised by Piper Sandler from $91.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) was downgraded by Wall Street Zen from "strong-buy" to "buy".
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) had its "underweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for HSIC provided by MarketBeat